Bellerophon Therapeutics Inc (NASDAQ:BLPH) entered into a license agreement for the development and commercialization of INOpulse with Baylor BioSciences.…
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today